Please login to the form below

Not currently logged in
Email:
Password:

Questcor Pharmaceuticals

This page shows the latest Questcor Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

Over the decades, other drugs superseded Acthar in many, but not all, indications, culminating in Aventis Pharmaceuticals selling the asset to Questcor for $100, 000 in 2001. ... Questcor allegedly increased the price to $750 immediately after buying the

Latest news

  • Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

    This includes the $5.6bn deal for Questcor Pharmaceuticals last year and its purchase of Cadence Pharmaceuticals for $1.3bn.

  • Questcor MS drug wins new indication

    Questcor Pharmaceuticals has won US Food and Drug Administration approval of a new indication for its for HP Acthar Gel. ... Questcor Pharmaceuticals, which specialises in drugs for difficult-to-treat diseases, has won US Food and Drug Administration (FDA

  • The Pump House

    Hepatitis. China. Mecasermin rinfabate. Iplex (Insmed). Growth disorders. US. Methylphenidate. Methylin Chewable Tablets (Alliant Pharmaceuticals). ... Quazepam. (Questcor Pharmaceuticals). Insomnia. US. Risperidone. Generic risperidone (Actavis Group).

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    All told 24% of its revenues will come from in consumer health, 62% pharmaceuticals and 14% vaccines. ... wholesale takeovers with deals in Devices (Biomet/ Zimmer Holdings, AccessClosure/ Cardinal Health; New Wave Surgical/ Covidien), Generics/

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Questcor appoints SVP corporate strategic development Questcor appoints SVP corporate strategic development

    Michael Aldridge joins from Australian early development company Xenome. US biopharma Questcor Pharmaceuticals has named Michael Aldridge as its first senior VP, corporate strategic development. ... Development programmes that complement Acthar are also

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....